Indication
In the female: Puregon is indicated for the treatment of female infertility in the following clinical situations: anovulation (including polycystic ovarian syndrome, PCOS) in women who have been unresponsive to treatment with clomifene citrate; controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs (e.g. in-vitro fertilisation / embryo transfer (IVF/ET), gamete intrafallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)).
In the male: Deficient spermatogenesis due to hypogonadotrophic hypogonadism.
Dans d’autres pays
Les mêmes substances actives dans d’autres registres, en commençant par la même marque.
Fiches nationales
Les registres nationaux où figure ce médicament de l’UE.